Searched for
BIOCON ACQUISITION
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...27 Apr, 2026, 08.52 AM IST- Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-ShawBiocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to accelerate gr...21 Nov, 2025, 12.19 AM IST
- Biocon shares jump 3% to hit new 52-week high on $4.5 billion Biologics IPO, merger reviewBiocon shares hit a new 52-week high after the company confirmed it is evaluating a potential merger of Biocon Biologics with the parent en...13 Nov, 2025, 10.56 AM IST
- Biocon considers merging Biocon Biologics in $4.5 billion deal; IPO and share swap options under reviewBiocon is exploring merging its biosimilars arm, Biocon Biologics, with itself, potentially valuing the unit at $4.5 billion. The company i...13 Nov, 2025, 07.16 AM IST
- Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiaryBiocon share price: Biocon reported a 96% year-on-year (YoY) decline in net profit, which fell to Rs 25 crore in Q3FY25. In comparison, the...31 Jan, 2025, 09.12 AM IST
- Biocon Biologics is planning to raise $950 million through overseas bondsBiocon Biologics plans to raise $950 million through overseas bond sales to refinance a significant portion of its $1.2-billion debt from a...14 Sep, 2024, 08.56 AM IST
- Biocon Biologics to raise debt of Rs 4,500 crore for Viatris PayoutBiocon Biologics plans to raise ₹4,500 crore with HSBC and MUFG's aid for a $175 million Aflibercept option. Previous funding by Kotak and ...12 Jul, 2024, 07.40 AM IST
- Biocon Q3 Results: PAT at Rs 660 crore vs Rs 42-crore loss a year agoThe company said the revenue growth was supported by income from the divesture of two non-core business assets of Biocon Biologics' branded...08 Feb, 2024, 10.52 PM IST
- Eris Lifesciences acquires Biocon Biologics' nephro, derma units for Rs 366 croreEris Lifesciences has announced that it has reached a definitive agreement to acquire the dermatology and nephrology branded formulations b...08 Nov, 2023, 05.14 PM IST
- Biocon acquires Eywa Pharma's US-based plant for $7.7 millionBiocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...02 Sep, 2023, 04.20 PM IST
- Kotak fund invests Rs 1070 crore in BioconEshwar Karra, CEO – Kotak Special Situations Fund at Kotak Investment Advisors said, We are delighted to partner with Biocon and this acqui...22 Feb, 2023, 10.16 PM IST
- Biocon raises $129 million from Kotak to fund biosimilars dealIndia's Kotak Mahindra Group asset management arm said on Wednesday it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to hel...22 Feb, 2023, 05.49 PM IST
- Biocon Biologics appoints Shreehas Tambe as MD & CEOTambe has been with Biocon since 1997 and has held diverse leadership and operational roles. Over the past 25 years, he has helped build an...05 Dec, 2022, 07.36 PM IST
- Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar businessThe transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the...16 Nov, 2022, 11.04 AM IST
- Biocon to acquire 26% stake in Hinduja Renewables TwoThe cost of the acquisition is Rs 5,91,61,730 for the acquisition of 26 percent stake on a fully diluted basis in one or more tranches, it ...23 Nov, 2020, 07.07 PM IST
- Biocon buys 70 pc of Germany's AxiCorpBiotechnology firm Biocon on Monday announced the acquisition of a 70 per cent stake in German pharmaceutical company, AxiCorp GmbH, for Eu...11 Feb, 2008, 10.59 AM IST
- Biocon's Shaw looks at acquisitions in IPsIndian pharma firms are increasing their market presence globally. Read Biocon's next strategic plans.29 Nov, 2006, 02.30 PM IST
Load More
